Vanderlene Liu Kung

Vanderlene Liu Kung is a researcher at Oregon Health & Science University specializing in nephrology, renal pathology, and clinical transplantation. Her work focuses on kidney allograft rejection, particularly antibody-mediated rejection and the molecular diagnosis of transplant injury using the Banff Human Organ Transplant gene panel. Recent contributions include investigating SGLT2 inhibitor effects on magnesium wasting in cisplatin-induced hypomagnesemia, recurrence of IgA nephropathy treated with iptacopan, and glomerulonephritis mimickers such as Bartonella endocarditis-associated disease. She has co-authored international multicenter studies and Banff working group reports shaping diagnostic criteria for transplant pathology.